You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 May 2026 - Citius Oncology Inc (Nasdaq:CTOR), a specialty biopharmaceutical company focused on the development and commercialisation of novel targeted oncology therapies, announced on Tuesday that it has entered into a senior secured term loan cred...
5 May 2026 - US life sciences company Lunai Bioworks Inc (NASDAQ:LNAI) announced on Monday the completion of a USD20m preferred equity issuance to acquire intellectual property assets from two counterparties, expanding the company's central nerv...
4 May 2026 - Norwegian bladder cancer company Photocure ASA (OSE: PHO) announced on Monday the publication of a new health economic methodology in The Journal of Medical Economics demonstrating that blue light cystoscopy is cost-effective compared wi...
4 May 2026 - Apotex Inc, a Canada-based global health company, announced on Friday that Health Canada has approved Apo-Semaglutide InjectionTM, a generic equivalent of Ozempic (semaglutide injection).Apotex is the first Canada-based pharmaceutical co...
4 May 2026 - Spinogenix Inc, a California-based clinical-stage biopharmaceutical company announced on Sunday that it will present the results of two new preclinical studies demonstrating the neuroprotective effects of tazbentetol (SPG302) in glaucoma...
4 May 2026 - Australia-based independent biopharmaceutical company Specialised Therapeutics (ST) announced on Sunday that its NIKTIMVO (axatilimab) has been approved for use in Australia by the Therapeutic Goods Administration (TGA) for the treatment...
1 May 2026 - Australian pharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Thursday that the marketing authorisation application (MAA) filed in Europe for TLX101-Px (O-(2-[18F] fluoroethyl)-L-tyrosine, 18F-FET),...